Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Minna

Showing results (11-20 of 489) with videos related to

Pageof 49
Sort By:
Nature Reviews. Drug Discovery|June 21, 2005
Erlotinib hydrochlorideJohn D Minna, Jonathan Dowell
Lancet (London, England)|March 6, 2012
A lung cancer molecular prognostic test ready for prime timeYang Xie, John D Minna
Clinics in Chest Medicine|November 8, 2011
Molecular biology of lung cancer: clinical implicationsJill E Larsen, John D Minna
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loopsAdi F Gazdar, John D Minna
Journal of the National Cancer Institute|April 9, 2009
Multifocal lung cancers--clonality vs field cancerization and does it matter?Adi F Gazdar, John D Minna
Plos Medicine|November 18, 2005
Inhibition of EGFR signaling: all mutations are not created equalAdi F Gazdar, John D Minna
Cell Stem Cell|July 13, 2010
Tumor oncogenotypes and lung cancer stem cell identityJames P Sullivan, John D Minna
Cancer Cell|December 16, 2010
ALK inhibition for non-small cell lung cancer: from discovery to therapy in record timeDavid E Gerber, John D Minna
Cancer Biology & Therapy|November 15, 2002
Inactivation of tumor suppressor genes by promoter methylation is important in the pathogenesis of pancreatic cancerJason B Fleming, John D Minna
Cell|July 16, 2016
Opening a Chromatin Gate to MetastasisJohn D Minna, Jane E Johnson
Pageof 49

Showing results (11-20 of 489) with videos related to

Sort By:
Pageof 49
Nature Reviews. Drug Discovery|June 21, 2005
Erlotinib hydrochlorideJohn D Minna, Jonathan Dowell
Lancet (London, England)|March 6, 2012
A lung cancer molecular prognostic test ready for prime timeYang Xie, John D Minna
Clinics in Chest Medicine|November 8, 2011
Molecular biology of lung cancer: clinical implicationsJill E Larsen, John D Minna
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loopsAdi F Gazdar, John D Minna
Journal of the National Cancer Institute|April 9, 2009
Multifocal lung cancers--clonality vs field cancerization and does it matter?Adi F Gazdar, John D Minna
Plos Medicine|November 18, 2005
Inhibition of EGFR signaling: all mutations are not created equalAdi F Gazdar, John D Minna
Cell Stem Cell|July 13, 2010
Tumor oncogenotypes and lung cancer stem cell identityJames P Sullivan, John D Minna
Cancer Cell|December 16, 2010
ALK inhibition for non-small cell lung cancer: from discovery to therapy in record timeDavid E Gerber, John D Minna
Cancer Biology & Therapy|November 15, 2002
Inactivation of tumor suppressor genes by promoter methylation is important in the pathogenesis of pancreatic cancerJason B Fleming, John D Minna
Cell|July 16, 2016
Opening a Chromatin Gate to MetastasisJohn D Minna, Jane E Johnson
Pageof 49